Visuomotor Control in Parkinson Disease

NCT ID: NCT06918938

Last Updated: 2025-08-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

63 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-19

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Visuomotor processing is the ability to integrate visual information into motor plans and movement correction, which is highly required in daily activities such as writing and walking. As visual impairments have been reported in people with Parkinson's disease (PD), it is likely that those impairments may affect visuomotor processing ability and subsequently impair motor performance. Furthermore, people with PD and freezing of gait (FOG) have exhibited poorer visual perception than those without FOG, yet the differences of visuomotor control have not been well investigated. Additionally, little did the studies apply neurophysiological assessment to investigate the associated neural mechanisms. This study aims to investigate behavioral and neurophysiological differences in visuomotor control among people with PD and FOG (freezers), without FOG (non-freezers), and age-matched healthy controls. Sixty-three participants, 21 freezers, 21 non-freezers, and 21 age-matched healthy controls, will be enrolled in this study. Behavioral assessments, including a manual control task and visual perception tests will be used to evaluate visuomotor and visual perceptual abilities. Neurophysiological correlates, including corticomotor excitability and corticocortical connectivity between V1-M1 and PPC-M1, will be examined using transcranial magnetic stimulation. It is hypothesized that freezers will demonstrate the greatest visuomotor impairments and disrupted corticocortical connectivity compared to non-freezers and controls. By integrating behavioral and neurophysiological outcomes, this study seeks to unravel the mechanisms linking visual and motor impairments to FOG, ultimately providing insights into targeted interventions to improve visuomotor processing and motor performance in PD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FOG

Participants with Parkinson disease and freezing of gait

No interventions assigned to this group

NFOG

Participants with Parkinson disease without freezing of gait

No interventions assigned to this group

CON

Age-matched healthy adults

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age above 18
* able to follow the researchers' instructions
* normal or correct-to-normal vision to view a computer screen

Exclusion Criteria

* neurological disorders other than PD
* diagnosed psychological disorders or a tendency of anxiety and/or depression
* a self-history of seizure or a family history of epilepsy
* deep brain stimulation or pacemaker implanted
* unstable cardiovascular diseases or other uncontrolled medical conditions
* pregnant
* surgical history, severe injury, or severe tremor of their upper extremities that can affect their movements in the past 6 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Graduate Institute of Physical Therapy

Role: PRINCIPAL_INVESTIGATOR

National Taiwan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

School and Graduate Institute of Physical Therapy

Taipei, Zhongzheng Dist., Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ya-Yun Lee, PhD

Role: CONTACT

+886-2-33668155

Sung-Hao Lu

Role: CONTACT

+886-9-79880052

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shwu-Fen Wang Director

Role: primary

886-2-33668156

References

Explore related publications, articles, or registry entries linked to this study.

Inzelberg R, Schechtman E, Hocherman S. Visuo-motor coordination deficits and motor impairments in Parkinson's disease. PLoS One. 2008;3(11):e3663. doi: 10.1371/journal.pone.0003663. Epub 2008 Nov 6.

Reference Type BACKGROUND
PMID: 18987752 (View on PubMed)

Palomar FJ, Conde V, Carrillo F, Fernandez-del-Olmo M, Koch G, Mir P. Parieto-motor functional connectivity is impaired in Parkinson's disease. Brain Stimul. 2013 Mar;6(2):147-54. doi: 10.1016/j.brs.2012.03.017. Epub 2012 Apr 15.

Reference Type BACKGROUND
PMID: 22537863 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202502008RINB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.